Moreover, as these tissue arrays do not provide information about neoadjuvant treatment, chemotherapy and radiotherapy, we could not perform a detailed analysis on NGF and MMP-2 levels in relation to the tumor stage. This evidence concerns the gene NGF and neoplasm.